Paperonium

Cancer genetics · JAMA · 2010

Paper: chance rarely makes its kidney-cancer gap between gene groups. Its own counts: 1 in 4.

1 in 1001 in 1,000every time1 in 20the usual barabout1 in 250The paper’s text: passesabout1 in 4Its own counts: fails
1 in 1001 in 1,000every time1 in 20the usual barabout1 in 250The paper’s text:passesabout1 in 4Its own counts: fails

How often chance alone makes a 9% vs 4% gap when risks are equal

The paper says

Kidney cancer hit 4 of 45 patients (9%) with a chemical tag on the KILLIN gene, versus 6 of 155 (4%) with a harmful PTEN mutation. The paper says chance alone would produce a gap this big only about 1 time in 250.

Its own data show

On its own counts, the test the paper says it used gives about 1 time in 4. The paper’s own pass mark is rarer than 1 time in 20. Other common tests give 1 in 10 to 1 in 3. Reaching 1 in 250 would take 8 kidney cancers among the 45, not 4.

Each “1 time in N” says how often chance alone would produce a gap at least this big if both groups truly had the same risk. With only 10 kidney cancers among 200 patients, a gap like this could easily be chance. So the paper’s own counts don’t back its advice of extra kidney checks for the KILLIN group.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Germline Epigenetic Regulation of KILLIN in Cowden and Cowden-Like Syndromes · JAMA (2010) · doi:10.1001/jama.2010.1877